Disease & disorder

opiate dependence

MONDO:0005530

Disorders related or resulting from abuse or mis-use of opioids.

Clinical trials35

Recruiting1

Drug concepts studied10

Synonyms2

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…

Clinical trials

35 shown

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.NCT05620940 · 2024-09-11

Accelerated Intermittent Theta-Burst Stimulation for Opiate Use DisorderNCT03804619 · 2024-01-01

Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in VietnamNCT04790201 · 2022-02-28

The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid DependenceNCT03575273 · 2018-02-12

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyNCT03549312 · 2018-02-01

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsNCT03089983 · 2017-08-21

Change the Cycle: An RCT to Prevent Injection InitiationNCT02774954 · 2016-06-01

Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid DependenceNCT02602795 · 2015-12-01

Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage IINCT02411357 · 2015-05-05

Study of Integrating Antiretroviral Therapy With Methadone Treatment for People Who Inject DrugsNCT02167425 · 2015-02-01

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release NaltrexoneNCT01882361 · 2013-06-01

Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in MalaysiaNCT01863251 · 2013-05-01

Pilot Test of a Community-based Buprenorphine Treatment InterventionNCT01761110 · 2012-12-01

Project FIRST - Financial Incentives to Reduce Substance Use and Improve TreatmentNCT01376570 · 2012-06-01

Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent PatientsNCT01645033 · 2012-04-01

Improving Effective Contraceptive Use Among Opioid-maintained WomenNCT01425060 · 2011-10-01

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in RussiaNCT01389167 · 2011-09-01

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice PopulationsNCT01246401 · 2011-03-01

Behavioral Drug and HIV Risk Reduction Counseling With MMT in ChinaNCT01389180 · 2010-12-01

Linking Hospitalized Injection Drug Users to BuprenorphineNCT00987961 · 2009-09-01

Methadone Maintenance & HIV Risk in UkraineNCT00351026 · 2008-06-01

The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist TreatmentNCT00857350 · 2008-06-01

Relapse Prevention to Reduce HIV Among Women PrisonersNCT00763958 · 2008-05-01

Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk ReductionNCT00609089 · 2008-03-01

Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in ChinaNCT00757744 · 2007-09-01

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in MalaysiaNCT00539123 · 2007-09-01

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug UsersNCT01741350 · 2006-09-01

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid DependenceNCT00548275 · 2006-07-01

Integrating Buprenorphine Into the SFGH AIDS ProgramNCT00263458 · 2005-12-01

Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent ParticipantsNCT00130819 · 2005-11-01

Integrating Buprenorphine Into HIV TreatmentNCT00241930 · 2005-09-01

The CORE Buprenorphine Project - An HIV Primary Care Program DemonstrationNCT00227357 · 2005-07-01

HIV Risk Reduction and Drug Abuse Treatment in IranNCT00398008 · 2004-10-01

Brief Introductory Therapy for Opioid DependenceNCT00406484 · 2004-09-01

HIV Risk Reduction and Drug Abuse Treatment in MalaysiaNCT00383045 · 2003-04-01

Drugs being studied

naltrexone2 atomoxetine1 Biktarvy1 buprenorphine1 Epclusa1 Genvoya1 isoniazid1 methadone1 rifapentine1 Vivitrol1

Research locations

New HavenConnecticut, United States9 BaltimoreMaryland, United States2 BurlingtonVermont, United States2 HartfordConnecticut, United States2 San FranciscoCalifornia, United States2 WuhanHubei, China2 BostonMassachusetts, United States1 ChicagoIllinois, United States1 ColumbusOhio, United States1 Los AngelesCalifornia, United States1 MoscowRussia1 New YorkNew York, United States1

Leading sponsors

Yale University13 Albert Einstein College of Medicine2 Johns Hopkins University2 University of Pennsylvania2 University of Vermont2 Butler Hospital1 Inventage Lab., Inc.1 Organization to Achieve Solutions in Substance Abuse (OASIS)1 Pangaea Global AIDS Foundation1 Rhode Island Hospital1 Ruth M. Rothstein CORE Center1 Saskatchewan Health Authority - Regina Area1 Stanford University1 University of Alabama at Birmingham1 University of California, San Francisco1

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.